These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18448834)

  • 41. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells.
    Oak JH; Nakagawa K; Oikawa S; Miyazawa T
    FEBS Lett; 2003 Dec; 555(2):419-23. PubMed ID: 14644453
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Simultaneous determination and quantification of seven major phospholipid classes in human blood using normal-phase liquid chromatography coupled with electrospray mass spectrometry and the application in diabetes nephropathy.
    Pang LQ; Liang QL; Wang YM; Ping L; Luo GA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jun; 869(1-2):118-25. PubMed ID: 18524699
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes.
    Lapolla A; Fedele D; Traldi P
    Mass Spectrom Rev; 2000; 19(5):279-304. PubMed ID: 11079246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Changes in the contents of membrane phospholipid and membrane phospholipid asymmetry in glucose-6-phosphate dehydrogenase deficient erythrocyte].
    Zou C; Tian X; Yan H
    Zhonghua Xue Ye Xue Za Zhi; 1998 Apr; 19(4):192-4. PubMed ID: 11243134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association of advanced glycation end-products with glutathione status.
    Sahin E; Göçmen AY; Koçak H; Tuncer M; Gümüslü S
    Ann Clin Biochem; 2008 Jul; 45(Pt 4):369-74. PubMed ID: 18583621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).
    Yamagishi S; Matsui T; Takenaka K; Nakamura K; Takeuchi M; Inoue H
    Diabetes Metab Res Rev; 2009 Mar; 25(3):266-71. PubMed ID: 19165765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substrate specificity of amadoriase I from Aspergillus fumigatus.
    Mennella C; Borrelli RC; Vinale F; Ruocco M; Fogliano V
    Ann N Y Acad Sci; 2005 Jun; 1043():837-44. PubMed ID: 16037311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A preliminary study on the formation pathways of glycated phosphatidylethanolamine of food rich in phospholipid during the heat-processing.
    Lin Q; Han L; Liu G; Cheng W; Wang L
    RSC Adv; 2018 Mar; 8(21):11280-11288. PubMed ID: 35542782
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro glycation and glycoxidation of phosphatidylethanolamines.
    Annibal A; Fedorova M; Schiller J; Hoffmann R
    Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S21-2. PubMed ID: 26461306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma alpha-oxoaldehyde levels in diabetic and nondiabetic chronic kidney disease patients.
    Nakayama K; Nakayama M; Iwabuchi M; Terawaki H; Sato T; Kohno M; Ito S
    Am J Nephrol; 2008; 28(6):871-8. PubMed ID: 18547947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Red blood cell adhesion in diabetes mellitus is mediated by advanced glycation end product receptor and is modulated by nitric oxide.
    Grossin N; Wautier MP; Wautier JL
    Biorheology; 2009; 46(1):63-72. PubMed ID: 19252229
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Amadori product on protein: structure and reactions.
    Baynes JW; Watkins NG; Fisher CI; Hull CJ; Patrick JS; Ahmed MU; Dunn JA; Thorpe SR
    Prog Clin Biol Res; 1989; 304():43-67. PubMed ID: 2675036
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phosphatidylethanolamines glycation, oxidation, and glycoxidation: effects on monocyte and dendritic cell stimulation.
    Simões C; Silva AC; Domingues P; Laranjeira P; Paiva A; Domingues MR
    Cell Biochem Biophys; 2013 Jul; 66(3):477-87. PubMed ID: 23250583
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications.
    Saraswat M; Reddy PY; Muthenna P; Reddy GB
    Br J Nutr; 2009 Jun; 101(11):1714-21. PubMed ID: 18986599
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of the amadori product in the complications of diabetes.
    Monnier VM; Sell DR; Dai Z; Nemet I; Collard F; Zhang J
    Ann N Y Acad Sci; 2008 Apr; 1126():81-8. PubMed ID: 18448799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ultra performance liquid chromatography-mass spectrometric determination of the site specificity of modification of beta-casein by glucose and methylglyoxal.
    Lima M; Moloney C; Ames JM
    Amino Acids; 2009 Mar; 36(3):475-81. PubMed ID: 18516664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for glucose-triggered modifications of glutathione.
    Jerić I; Horvat S
    J Pept Sci; 2009 Aug; 15(8):540-7. PubMed ID: 19579211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The selective utilization of substrates in vivo by the phosphatidylethanolamine and phosphatidylcholine biosynthetic enzymes Ept1p and Cpt1p in yeast.
    Boumann HA; de Kruijff B; Heck AJ; de Kroon AI
    FEBS Lett; 2004 Jul; 569(1-3):173-7. PubMed ID: 15225629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma glycooxidation protein products in type 2 diabetic patients with nephropathy.
    Piwowar A; Knapik-Kordecka M; Szczecińska J; Warwas M
    Diabetes Metab Res Rev; 2008 Oct; 24(7):549-53. PubMed ID: 18613218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strategies for proteomic analysis of non-enzymatically glycated proteins.
    Priego Capote F; Sanchez JC
    Mass Spectrom Rev; 2009; 28(1):135-46. PubMed ID: 18949816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.